Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity

Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Ekaterina V. Tikhonenko, Alina Y. Babenko, Evgeny V. Shlyakhto
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrinology Research Centre 2018-12-01
coleção:Ожирение и метаболизм
Assuntos:
diabetes type 2
obesity
glucagon-like peptide-1 receptor agonists
glucagon-like peptide-1
ghrelin
food behavior
Acesso em linha:https://www.omet-endojournals.ru/jour/article/view/9584
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados